Loading...
Regulatory T cells and treatment of cancer
CD4(+)CD25(+)Foxp3(+) regulatory T cells are elevated in cancers and can thwart protective anti-tumor immunity. Recent human cancer trials suggest that depleting regulatory T cells can be clinically beneficial. Additional types of deleterious regulatory cells are also increased in cancer. Regulatory...
Na minha lista:
| Hovedforfatter: | |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2008
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3319305/ https://ncbi.nlm.nih.gov/pubmed/18508251 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.coi.2008.04.008 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|